JY
LSB

Jeff Yass’s LakeShore Biopharma LSB Stock Holding History

Jeff Yass’s Portfolio LSB Stock Details LSB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-1,167
Closed -$7.56K – 13236
2024
Q2 		$7.56K Buy
+1,167
New +$9.54K ﹤0.01% 11800
2023
Q3 		– Sell
-1,526
Closed -$21.1K – 13167
2023
Q2 		$21.1K Buy
+1,526
New +$22.6K ﹤0.01% 11625

Other funds holding LSB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $139B AUM 29.06% 1-Year Est. Return
SCM
Superstring Capital Management New York $158M AUM 418.32% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $304B AUM 35.64% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Jeff Yass's LSB Position: Q3 2024 in Review

Jeff Yass sold out of LakeShore Biopharma (LSB) in Q3 2024, closing a stake of 1,167 shares — an estimated $7.56K sold.

Jeff Yass first reported a position in LSB in Q2 2023 and held it in 2 quarters. The position peaked at $21.1K in Q2 2023. 7 funds tracked by Wall St. Rank hold LSB as of Q3 2024.

  • Jeff Yass reported no remaining LakeShore Biopharma position as of Q3 2024 after selling out during the quarter.
  • Jeff Yass sold 1,167 LakeShore Biopharma shares in Q3 2024, an estimated $7.56K.
  • Jeff Yass first reported a position in LakeShore Biopharma in Q2 2023 and held it in 2 quarters.
  • Jeff Yass's LakeShore Biopharma position peaked at $21.1K in Q2 2023.
  • 7 funds tracked by Wall St. Rank held LakeShore Biopharma as of Q3 2024.

Based on Susquehanna International Group's 13F filing for Q3 2024, filed 14 Nov 2024.